Dr. B

Dr. B provides access to low-cost telehealth consultations for prescription medication with a no-cost option. Patients first complete an electronic medical assessment after which they have access to virtual consultations with physicians and are prescribed medications based on their needs. Dr. B has launched its service focusing on the prescription of two FDA-approved oral antivirals that treat Covid-19.

As of August 2022, the company’s services are currently available in more than 40 states.

Funding and financials

In August 2022, Dr. B raised USD 8 million in a funding round led by Lerer Hippeau and Founders Fund along with participation from other investors. The funds were set aside to expand geographical access to the platform’s everyday prescriptions via its “Visitless Prescription” service.